Nature’s Sunshine Products, Inc. has announced the launch of an underwritten secondary public offering of up to 2,854,607 shares of its common stock, to be sold by Fosun Pharma USA, Inc. The proceeds ...
Nature’s Sunshine delivered strong Q3 2025 results, driven by robust growth in Asia and recurring autoship sales. NATR's international focus, especially in Asia and Europe, positions it for continued ...
LEHI, Utah, June 26, 2025 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (NASDAQ: NATR) (“Nature’s Sunshine” or the “Company”), a leading manufacturer of high-quality herbal and nutritional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results